MLN9708 and Dexamethasone for High-Risk Smoldering Multiple Myeloma
- Status
- WITHDRAWN
- Phase
- PHASE2
Clinical Trials Related to Multiple Myeloma
Related studies linked through entity extraction aliases.
A Safety Study of Carfilzomib, Cyclophosphamide & Dexamethasone Prior to ASCT in Patients With Newly Diagnosed Myeloma
- Status
- COMPLETED
- Phase
- PHASE1
Safety & Efficacy Study High Dose Evomela Injection for MA Conditioning in MM Patients With Autologous Transplantation
- Status
- COMPLETED
- Phase
- PHASE2
Carfilzomib and Stem Cell Transplant for Plasma Cell Myeloma
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Panobinostat Biological Correlates Study
- Status
- COMPLETED
- Phase
- PHASE2
Phase II Study of V-BEAM Conditioning Regimen Prior to Second Autologous Stem Cell Transplantation
- Status
- TERMINATED
- Phase
- PHASE2
Phase II, Single-Center, Oral Panobinostat in Combination With Lenalidomide and Dexamethasone in Multiple Myeloma (MM)
- Status
- COMPLETED
- Phase
- PHASE2
Phase II Study of Subcutaneous (SC) Bortezomib, Lenalidomide and Dexamethasone for Relapsed and/or Refractory Multiple Myeloma; Followed by SC Bortezomib Maintenance
- Status
- WITHDRAWN
- Phase
- PHASE2
Phase 1 Pharmacokinetic Study of Oral Ixazomib Plus Lenalidomide and Dexamethasone in Adult Asian Participants With Relapsed and/or Refractory Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE1
Dasatinib for Immune Modulation After Donor Stem Cell Transplant for Hematologic Malignancies
- Status
- TERMINATED
- Phase
- PHASE1
BT062 in Combination With Lenalidomide or Pomalidomide and Dexamethasone in Patients With Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Inducible Regulatory T Cells (iTregs) in Non-Myeloablative Sibling Donor Peripheral Blood Stem Cell Transplantation
- Status
- COMPLETED
- Phase
- PHASE1
Pomalidomide (POM) in Combination With Low Dose Dexamethasone (LD-Dex) in Patients With Relapsed or Refractory Multiple Myeloma
- Status
- APPROVED_FOR_MARKETING
- Phase
- N/A
Biosimilar Retacritâ„¢ (Epoetin Zeta) in the Treatment of Chemotherapy-Induced Symptomatic Anaemia in Haematology and Oncology
- Status
- COMPLETED
- Phase
- N/A
Engraftment Syndrome After Autologous Stem Cell Transplant: Retrospective Review in Patients With Multiple Myeloma
- Status
- COMPLETED
- Phase
- N/A
UARK 2009-09 Myeloma Cure Project: Prospective Trial of Indefinite Revlimid Maintenance Versus Observation for Currently Event-Free Patients With Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE3
Genomic-Based Diagnosis, Classification and Targeted Treatment of Multiple Myeloma
- Status
- UNKNOWN
- Phase
- N/A
Autologous Stem Cell Transplantation and Maintenance Therapy for Multiple Myeloma
- Status
- TERMINATED
- Phase
- PHASE2
Daratumumab in Combination With Lenalidomide and Dexamethasone in Relapsed and Relapsed-refractory Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Pilot Study of Lymphoid Tumor Microenvironmental Dysruption Prior to Autologous Stem Cell Transplantation
- Status
- TERMINATED
- Phase
- PHASE1